Will Trump ' s Leadership Picks Smack Down Health Care? - A Drug Company Lobbyist, an Entrepreneur Who Wants to Weaken Drug Testing, and a Mysterious Billionaire Who Settled Fraud Charges

President Trump in hisinauguration speech promised to reach out to " struggling families " and to benefit " American workers and American families, " and promised all Americans " you will never be ignored again. "  Yet the Trump transition team, and now presidential administration continues to consider individuals for health care policy leadership roles remarkable for theirconflicts of interest, which often did not merely arise from small financial transactions but from their roles as corporate insiders, and in some cases, association with dubiously ethical practices.  They are particularly unremarkable for their lack of interest in, if not ignorance of American workers ' and families ' health, except perhaps as a vehicle for personal profit. Discussed in order of increasing potential power.Jack Kalavritinos for FDA " Beachhead Team "As reported by StatNews (unfortunately behind a paywall) on January 19,Former pharmaceutical lobbyist Jack Kalavritinos, who also worked in various capacities for the George W. Bush administration, will take a major role on the ' beachhead ' team that the incoming Trump administration is sending to run the Food and Drug Administration following Friday ’s inauguration, transition team sources say.Kalavritinos spent seven years asdirector of global lobbying for the Irish pharmaceutical and medical device company Covidien, which sells a wide array of hospital supplies around the world.  The US company Medtro...
Source: Health Care Renewal - Category: Health Management Tags: conflicts of interest Covidien Donald Trump executive compensation fraud Medtronic revolving doors Source Type: blogs